Linked e-resources
Details
Table of Contents
Part I. Introduction. Cancer Immunology and the evolution of immunotherapy ; Cancer immunotherapy: overview of immune checkpoint inhibitors ; Immunopathogenesis of immune-related adverse events from cancer immunotherapy
Part II. Immune-related adverse events with immune-checkpoint inhibitors. Arthritis ; Polymyalgia rheumatica ; Myositis ; Sicca syndromes ; Sarcoidosis ; Miscellaneous rheumatic syndromes ; Non-rheumatic immune-related adverse events ; Immune-related adverse events with other cancer immunotherapies
Part III. Cancer immunotherapy in patients with pre-existing rheumatic diseases. Inflammatory arthritis ; Other rheumatic autoimmune diseases
Part IV. General principles of management. Management of rheumatic immune-related adverse events (irAEs): general principles ; Benefit-risk considerations ; Patient education and shared-decision making.
Part II. Immune-related adverse events with immune-checkpoint inhibitors. Arthritis ; Polymyalgia rheumatica ; Myositis ; Sicca syndromes ; Sarcoidosis ; Miscellaneous rheumatic syndromes ; Non-rheumatic immune-related adverse events ; Immune-related adverse events with other cancer immunotherapies
Part III. Cancer immunotherapy in patients with pre-existing rheumatic diseases. Inflammatory arthritis ; Other rheumatic autoimmune diseases
Part IV. General principles of management. Management of rheumatic immune-related adverse events (irAEs): general principles ; Benefit-risk considerations ; Patient education and shared-decision making.